Zolendronic Acid Prevents Bone Loss after Liver Transplantation

Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.

What is the problem and what is known about it so far?

Doctors estimate that between 16% and 40% of patients who undergo liver transplantation have bone fractures within 3 …

« Previous | Next Article »Table of Contents